Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Leukoc Biol ; 88(2): 303-11, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20356901

ABSTRACT

IL-10, a potent anti-inflammatory cytokine, activates its primary mediator STAT3 to exert inhibitory effects on activated immune response. It has been reported that IFN-gamma signaling can be suppressed by IL-10, which deactivates macrophages and suppresses cell-mediated antigen presentation. Cathepsin S, a cysteine protease, plays a significant role in the antigen processing. We hypothesize that the IL-10-induced and STAT3-mediated signaling pathway interferes with IFN-gamma-induced immune responses in primary human blood macrophages. Here, we investigated whether IL-10 perturbs MHC-II levels via its effect on cathepsin S expression in antigen processing. We showed that the expression of cathepsin S and MHC-II, inducible by IFN-gamma, was down-regulated in the presence of IL-10. Additionally, we revealed that the inhibitory effect of IL-10 was demonstrated to be independent of the classical IFN-gamma-induced JAK2/STAT1 signaling cascade or the NF-kappaB pathway. Following STAT3 suppression with specific siRNA, the expression of IFN-gamma-induced surface MHC-II antigens and cathepsin S levels was restored, even in the presence of IL-10. Taken together, our results demonstrated that the immunosuppressive effects of IL-10-STAT3 on MHC-II antigen presentation may occur via the inhibition of cathepsin S expression.


Subject(s)
Cathepsins/genetics , Histocompatibility Antigens Class II/genetics , Interleukin-10/pharmacology , Macrophages/immunology , STAT3 Transcription Factor/physiology , Blood Cells , Cathepsins/physiology , Down-Regulation/genetics , Humans , Immunity , Interferon-gamma
2.
BMC Immunol ; 10: 64, 2009 Dec 17.
Article in English | MEDLINE | ID: mdl-20017901

ABSTRACT

BACKGROUND: Mycobacterium tuberculosis (MTB) is a major cause of morbidity and mortality in the world. To combat against this pathogen, immune cells release cytokines including tumor necrosis factor-alpha (TNF-alpha), which is pivotal in the development of protective granulomas. Our previous results showed that Bacillus Calmette Guerin (BCG), a mycobacterium used as a model to investigate the immune response against MTB, stimulates the induction of TNF-alpha via mitogen-activated protein kinase (MAPK) in human blood monocytes. Since MAPK phosphatase-1 (MKP-1) is known to regulate MAPK activities, we examined whether MKP-1 plays a role in BCG-induced MAPK activation and cytokine expression. RESULTS: Primary human blood monocytes were treated with BCG and assayed for MKP-1 expression. Our results demonstrated that following exposure to BCG, there was an increase in the expression of MKP-1. Additionally, the induction of MKP-1 was regulated by p38 MAPK and extracellular signal-regulated kinase 1 and 2 (ERK1/2). Surprisingly, when MKP-1 expression was blocked by its specific siRNA, there was a significant decrease in the levels of phospho-MAPK (p38 MAPK and ERK1/2) and TNF-alpha inducible by BCG. CONCLUSIONS: Since TNF-alpha is pivotal in granuloma formation, the results indicated an unexpected positive function of MKP-1 against mycobacterial infection as opposed to its usual phosphatase activity.


Subject(s)
Anti-Bacterial Agents/pharmacology , Dual Specificity Phosphatase 1/physiology , Mycobacterium bovis/physiology , Cysteine/analogs & derivatives , Cysteine/pharmacology , Enzyme Induction , Humans , Lipopolysaccharides/pharmacology , Lipoproteins/pharmacology , Mitogen-Activated Protein Kinase 1/physiology , Mitogen-Activated Protein Kinase 3/physiology , Monocytes/physiology , RNA, Small Interfering/pharmacology , Transfection , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/physiology , p38 Mitogen-Activated Protein Kinases/physiology
3.
J Med Chem ; 52(21): 6707-15, 2009 Nov 12.
Article in English | MEDLINE | ID: mdl-19835377

ABSTRACT

Cimicifuga species have been used as traditional medicinal herbs to treat inflammation and symptoms associated with menopause in Asia, Europe, and North America. However, the underlying mechanism of their anti-inflammatory effects remains to be investigated. With bioactivity guided purification involving the use of partitioning extraction and high performance liquid chromatography, we isolated one of the key bioactive constituents from the rhizome extracts of Cimicifuga racemosa. By NMR spectroscopy, the molecule was identified to be cimiracemate A (1). This compound (140 muM) suppressed the lipopolysaccharide-induced TNF-alpha production in the blood macrophages by 47 +/- 19% and 58 +/- 30% at LPS concentrations of 1 ng/mL and 10 ng/mL, respectively. The anti-inflammatory activity of compound 1 may be due to its modulation of a signaling mitogen activated protein kinase and transcription factor nuclear factor-kappaB activities. Compound 1 was found in other Cimicifuga species. Our data indicate that compound 1 or its chemical analogues may have the potential to be further developed as a new class of therapeutic agent.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Cimicifuga/chemistry , Cinnamates/isolation & purification , Macrophages/drug effects , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cells, Cultured , Chromatography, High Pressure Liquid , Cinnamates/chemistry , Cinnamates/pharmacology , Down-Regulation , Humans , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Magnetic Resonance Spectroscopy , Mitogen-Activated Protein Kinases/blood , NF-kappa B/blood , Plant Extracts/chemistry , Rhizome/chemistry , Tumor Necrosis Factor-alpha/biosynthesis
4.
J Leukoc Biol ; 86(2): 283-91, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19401395

ABSTRACT

Mtb dysregulates monocyte/macrophage functions to produce a large amount of the immunosuppressive cytokine IL-10. An important function of IL-10 in promoting Mtb survival is the suppression of antigen presentation of monocytes/macrophages to T cells. This dampens the host immune responses and provides an opportunity for immune evasion. GSK3 has been shown to control the balance between pro- and anti-inflammatory cytokine productions. Here, we investigated whether GSK3 regulates IL-10 expression and mediates a protective role upon live mycobacterial challenge using BCG as a model. Our results showed that BCG increased Akt phosphorylation and inhibited GSK3 activity, resulting in increased IL-10 production. We confirmed further that suppression of GSK3 activities by a specific chemical inhibitor strongly enhanced BCG-induced IL-10 production. We also showed that IL-10 secreted by BCG-infected human PBMo was a major suppressor of subsequent IFN-gamma production by PBMC and HLA-DR expression on PBMo in response to BCG. Neutralization of PBMo-secreted IL-10 by anti-IL-10 antibodies restored the IFN-gamma production and HLA-DR surface expression. Taken together, GSK3 negatively regulates mycobacteria-induced IL-10 production in human PBMo. The kinase may play a role in restoring IFN-gamma secretions and subsequent antigen presentation in response to mycobacterial infection. In conclusion, our results suggest a significant role for GSK3 in guarding against mycobacterial evasion of immunity via IL-10 induction in the host.


Subject(s)
Glycogen Synthase Kinase 3/physiology , Immune Tolerance/immunology , Immunity, Innate/immunology , Interleukin-10/metabolism , Mycobacterium Infections/immunology , Mycobacterium/immunology , Antibodies/pharmacology , Cells, Cultured , Down-Regulation/immunology , Enzyme Activation/drug effects , Enzyme Activation/immunology , Enzyme Inhibitors/pharmacology , Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3/metabolism , HLA-DR Antigens/metabolism , Humans , Interferon-gamma/metabolism , Interleukin-10/antagonists & inhibitors , Monocytes/immunology , Monocytes/microbiology , Mycobacterium Infections/physiopathology , Mycobacterium bovis/immunology , Oncogene Protein v-akt/metabolism , Phosphorylation
5.
Int J Cancer ; 121(6): 1190-6, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17520672

ABSTRACT

Induction of proinflammatory cytokines in response to malignant cells is an integral component of immune response to control tumor development. However, recent evidences have suggested that tumor cells may evade the immune system and exploit inflammatory responses to enhance its own growth. An exemplary example is the highly invasive and tumor necrosis factor (TNF)alpha-resistant glioblastoma, whose growth is associated with TNFalpha expression. We thus examined whether the tumor takes advantage of TNFalpha overexpression to enhance its invasiveness. To delineate the contribution of inflammation in tumor migration, we demonstrated that the role of proinflammatory cytokines on matrix metalloproteinases-3 (MMP-3) expression, and its consequent effects on the invasiveness of a human glioma cell-line, T98G. By using Matrigel Invasion Chamber, T98G cell migration was significantly enhanced in response to TNFalpha. In contrast, interferon-gamma (IFN gamma) reduced both basal and TNFalpha-enhanced cell invasion. To investigate the mechanisms involved, we demonstrated that TNFalpha upregulated mRNA and protein expression of MMP-3 in T98G cells, whereas IFN gamma downregulated the MMP-3 expression. The role of MMP-3 in glioma invasiveness was further confirmed by transfecting MMP-3 siRNA in T98G to abrogate the TNFalpha-enhanced cell invasion. To delineate the mechanisms further, we showed that IFN gamma exerts an inhibitory effect on the binding of TNFalpha-activated Ets-1 and NF kappa B to their respective enhancer elements found in MMP-3 promoter. In summary, our results indicated that TNFalpha enhances the invasiveness of T98G glioma cells through MMP-3 induction, and such enhancement of cell migration can be inhibited by IFN gamma.


Subject(s)
Cell Movement/physiology , Glioma/metabolism , Interferon-gamma/metabolism , Matrix Metalloproteinase 3/biosynthesis , Tumor Necrosis Factor-alpha/metabolism , Cell Line, Tumor , Electrophoretic Mobility Shift Assay , Gene Expression , Glioma/immunology , Humans , Interferon-gamma/immunology , Matrix Metalloproteinase 3/immunology , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/immunology
6.
J Virol ; 81(1): 416-22, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17035307

ABSTRACT

Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus. Since its associated morbidity and mortality have been postulated to be due to immune dysregulation, we investigated which of the viral proteins is responsible for chemokine overexpression. To delineate the viral and cellular factor interactions, the role of four SARS coronavirus proteins, including nonstructural protein 1 (nsp-1), nsp-5, envelope, and membrane, were examined in terms of cytokine induction. Our results showed that the SARS coronavirus nsp-1 plays an important role in CCL5, CXCL10, and CCL3 expression in human lung epithelial cells via the activation of NF-kappaB.


Subject(s)
Chemokines/genetics , Severe acute respiratory syndrome-related coronavirus/pathogenicity , Viral Nonstructural Proteins/metabolism , Chemokine CCL3 , Chemokine CCL5 , Chemokine CXCL10 , Chemokines/metabolism , Chemokines, CC/genetics , Chemokines, CC/metabolism , Chemokines, CXC/genetics , Chemokines, CXC/metabolism , Gene Expression Regulation , NF-kappa B/genetics , NF-kappa B/metabolism , Respiratory Mucosa/cytology , Respiratory Mucosa/virology , Severe acute respiratory syndrome-related coronavirus/metabolism , Viral Envelope Proteins/physiology , Viral Matrix Proteins/physiology
7.
J Immunol ; 175(11): 7218-25, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16301626

ABSTRACT

Following infection of the host by Mycobacterium tuberculosis, induction of cytokines is a major defense mechanism to limit the pathogen invasion. Cytokines interact with each other to form an intertwined network of pathways. For example, IFN and TNF have been shown to interact through common pathways including IFN-inducible, dsRNA-activated serine/threonine protein kinase (PKR) induction. As a signal transducer, it has been conventionally known to regulate the induction of cytokine expression in response to virus infection through NF-kappaB. In light of the critical role of TNF in immunity and its cytotoxic effects mediated by PKR, we examined the role of the kinase in the regulation of immune response against M. tuberculosis using the interaction of bacillus Calmette-Guérin (BCG) and primary human blood monocytes as a model. Our results showed that BCG stimulates the induction of cytokine expression in human primary blood monocytes including TNF-alpha, IL-6, and IL-10. With the suppression of PKR by using PKR-mutant gene or 2-aminopurine as PKR inhibitor, we showed that the BCG-induced cytokine expression in human monocytes is regulated by the phosphorylation and activation of PKR. We also demonstrated that downstream of PKR induction is the activation of MAPK and translocation of NF-kappaB into the nucleus. NF-kappaB in turn mediates the transcription of specific cytokine genes. Taken together, PKR plays a critical role in the regulation of immune responses to mycobacterial infection and may serve as an important molecule in the innate antimycobacterial defense.


Subject(s)
Cytokines/biosynthesis , Monocytes/immunology , Monocytes/microbiology , Mycobacterium Infections/immunology , eIF-2 Kinase/metabolism , Animals , Blotting, Western , Electrophoretic Mobility Shift Assay , Gene Expression , Humans , MAP Kinase Signaling System/immunology , Mycobacterium bovis/immunology , NF-kappa B/immunology , NF-kappa B/metabolism , Phosphorylation , Reverse Transcriptase Polymerase Chain Reaction , U937 Cells , eIF-2 Kinase/immunology
8.
FEBS Lett ; 579(14): 3055-62, 2005 Jun 06.
Article in English | MEDLINE | ID: mdl-15907845

ABSTRACT

HIV Tat has been known to have multiple regulatory roles including replication of HIV and modulation of cellular kinases. We investigated whether signaling kinase PKR plays a critical role in mediating Tat-induced cytokine dysregulation. We showed Tat induction of IL-10 dysregulation is associated with PKR activation. To examine the mechanism involved, inhibition of PKR activity abrogated the Tat-induced cytokine induction. We next identified that the MAP kinases including ERK-1/2 and p38 are downstream of PKR in these Tat-induced pathways. Thus, PKR may play a critical role in mediating the subversive effects of HIV Tat resulting in IL-10 induction.


Subject(s)
Cytokines/genetics , Cytokines/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Products, tat/metabolism , MAP Kinase Signaling System , eIF-2 Kinase/immunology , eIF-2 Kinase/metabolism , CCAAT-Enhancer-Binding Protein-delta , CCAAT-Enhancer-Binding Proteins/metabolism , Cells, Cultured , Cytokines/biosynthesis , Cytokines/immunology , Dose-Response Relationship, Drug , HIV-1 , Humans , Interleukin-10/biosynthesis , Interleukin-10/genetics , Interleukin-10/metabolism , Leukocytes/metabolism , NF-kappa B/metabolism , Time Factors , Transcription Factors/metabolism , Up-Regulation , eIF-2 Kinase/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism , tat Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...